b RAS G12, G13 or Q61 mut or no RAS mut identified. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting II. This abstract does not include a full text component.

This year’s meeting of the American Society of Clinical Oncology is abuzz with talk of RAS inhibitors, largely driven by Revolution Medicines’ barnburner pancreatic cancer data drop earlier this year.

The Higher Education Commission of Pakistan (HEC) on Monday announced the launch of a “fully online and paperless” degree attestation system to facilitate students. In December last year, the HEC said ...

Revolution Medicines’ pan-RAS inhibitor helped patients with a highly aggressive form of pancreatic cancer live an average of six months longer than chemotherapy, hitting a goal of the phase 3 study.

PARIS — RAS Luxury Skincare, the Indian farm-to-face brand, closed a 65 Crores, or $7.5 million, Series B funding round led by Dabur Ventures. Dabur Ventures is the venture arm of the largest ...

WAUKEE – Chicago Cubs minor-league pitcher Tyler Ras stands to the side of the indoor baseball field at SportsPlex West on a January evening, tossing balls to high school players on the club team, the ...

Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...

Instagram's new feature that shows users' current locations is prompting some users to worry if their location will suddenly be shared on the platform. Meta announced the rollout of several new ...

I am a proud, unapologetic progressive with a proven track record of action to protect our most vulnerable residents, create better education for our children, and forge pathways to affordable rent ...

Ras Baraka's May 9 arrest outside an ICE detention center in New Jersey has created tensions between three congressional Democrats and the Trump administration. Newark Mayor Ras Baraka speaks to ...

KRASG12C-targeted therapies like sotorasib and adagrasib have been approved, but resistance challenges persist, necessitating further research into RAS(ON) therapies. Revolution Medicines is ...